Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension
Cugini, P.; Serdoz, R.; Manconi, R.; Mancini, A.; Meucci, T.
Bollettino della Societa Italiana di Biologia Sperimentale 54(2): 111-115
1978
ISSN/ISBN: 0037-8771 PMID: 737057 Document Number: 130831
Document emailed within 1 workday
Related Documents
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941Takeda, Y.; Miyamori, I.; Ikeda, M.; Koshida, H.; Yasuhara, S.; Nagai, K.; Morise, T.; Takimoto, H.; Takeda, R. 1985: Responses of plasma bradykinin and the renin-angiotensin axis to furosemide in essential hypertension Nihon Jinzo Gakkai Shi 27(4): 525-531
Hornych, A.; London, G.; Safar, M.; Weiss, Y.; Simon, A.; Guyene, T.T.; Bariéty, J.; Milliez, P. 1978: Plasma prostaglandins and the renin-aldosterone system in patients with labile or permanent essential hypertension Journal d'Urologie et de Nephrologie 84(12): 843-849
Fang, C.C.; Chen, Y.M.; Chu, T.S.; Hsieh, B.S. 1993: Correlation between renin responsiveness to furosemide and antihypertensive effect of captopril in patients with normal-renin essential hypertension Journal of the Formosan Medical Association 92(11): 937-941
Cerasola, G.; Cottone, S.; Mangano, M.T.; D'Ignoto, G.; Pinto, A.; Carone, M.B. 1988: Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension Clinical Therapeutics 10(6): 694-703
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Kondo, K.; Morotomi, Y.; Tanaka, K. 1984: Effects of captopril on renin-angiotensin-aldosterone system and kallikrein-kinin system in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(11): 1487-1493
Zelnick, N.; Boner, G.; Rosenfeld, J. 1982: The renin-aldosterone system in the diagnosis of essential hypertension Harefuah 102(4): 139-141
Pirrelli, A.; Pieri, R.; Dolce, E. 1976: Correlations between plasmatic renin and aldosterone in essential arterial hypertension with sympathetic hyperactivity Bollettino Della Societa Italiana di Cardiologia 21(3): 511-515
García Zozaya, J.L.; Padilla Viloria, M. 1997: Alterations of calcium, magnesium, and zinc in essential hypertension:their relation to the renin-angiotensin-aldosterone system Investigacion Clinica 38(Suppl 2): 27-40
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
Gordon, R.D.; Gomez-Sanchez, C.E.; Hamlet, S.M.; Tunny, T.J.; Klemm, S.A. 1987: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 5(5): S103-S106
Wnuk, R.; Kokot, F. 1991: Effect of nifedipine treatment on the renin-aldosterone system and secretion of cortisol and growth hormone in patients with essential hypertension Endokrynologia Polska 42(3): 421-427
Pratt, J.H.; Luft, F.C. 1979: The effect of extremely high sodium intake on plasma renin activity, plasma aldosterone concentration, and urinary excretion of aldosterone metabolites Journal of Laboratory and Clinical Medicine 93(5): 724-729
Klumpp, F.; Braun, B.; Lemke, R.; Zehner, J.; Klaus, D. 1976: Plasma renin and aldosterone in parenchymal renal hypertension during stimulation and suppression conditions Die Medizinische Welt 27(47): 2283-2285
Memezawa, H.; Abe, K.; Irokawa, N.; Chiba, H.; Yasujima, M. 1975: Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide Nihon Jinzo Gakkai Shi 17(2): 63-68
Garcia Zozaya, J.L.; Padilla Viloria, M.; Castro, A. 1987: Essential arterial hypertension: plasma and urinary aldosterone alterations Southern Medical Journal 80(10): 1224-1227
Irokawa, N.; Abe, K.; Aoyagi, H.; Memezawa, H.; Yasujima, M. 1973: Plasma renin activity in essential hypertension Nihon Jinzo Gakkai Shi 15(11): 949-960
Milicević, Z.; Jelaković, B.; Marinković, M. 1994: Hyperuricemia and plasma renin activity in essential arterial hypertension Lijecnicki Vjesnik 116(1-2): 14-17
Oelkers, W.; Blümel, A.; Schöneshöfer, M.; Schwartz, U.; Hammerstein, J. 1976: Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men Journal of Clinical Endocrinology and Metabolism 43(5): 1036-1040